Concepedia
Statistics
Publications
15
Citations
887
H-Index
12
Active since
1979
Affiliations
Pfizer (Japan)(Current)
Mie University
Pfizer (United States)
Nagoya University
Mayumi Mizutani is an author at Pfizer (Japan) specializing in pharmacology, medicine, and molecular pharmacology.
Top concepts
MedicinePharmacologyMolecular PharmacologyPharmacotherapyDrug DiscoveryHealthPhysiologyBiochemistryNeuropharmacologyNatural Sciences
Publications per year
1979–2023
Genetic Polymorphism in the 5'-Flanking Region of HumanCYP1A2 Gene: Effect on the CYP1A2 Inducibility in Humans
Mitsutoshi Nakajima, Tsuyoshi Yokoi, Mayumi Mizutani et al. · The Journal of Biochemistry · 1999 · 345 citations
Molecular Pharmacology, 5'-Flanking Region, Genetics +14
Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
Miki Nakajima, Tsuyoshi Yokoi, Mayumi Mizutani et al. · PubMed · 1994 · 142 citations
Cyp1a2 Gene, Urology, Japanese Population +15
Antinociceptive activity of CP‐101,606, an NMDA receptor NR2B subunit antagonist
Kana Taniguchi, Katsuhiro Shinjo, Mayumi Mizutani et al. · British Journal of Pharmacology · 1997 · 127 citations · Full text
Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist ‘CJ-17,493’
Yuji Shishido, H. Wakabayashi, Hiroki Koike et al. · Bioorganic & Medicinal Chemistry · 2008 · 64 citations · Full text
Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9
Bacillus Calmette‐Guérin perfusion therapy for carcinoma <i>in situ</i> of the upper urinary tract
Hiroyuki Yokogi, Yakihiro Wada, Mayumi Mizutani et al. · British Journal of Urology · 1996 · 51 citations
1–5 of 15